Profile data is unavailable for this security.
About the company
Linical Co., Ltd. is a Japan-based company mainly engaged in the contract research organization (CRO) business for drug companies. The Company operates in two businesses. The CRO segment is engaged in the provision of contract monitoring, quality management and consulting services for phase II and phase III in drug development processes. The Pharmaceutical Sales Support segment is engaged in provision of pharmaceutical sales support for medical institutions in the downstream market.
- Revenue in JPY (TTM)9.87bn
- Net income in JPY-1.19bn
- Incorporated2005
- Employees598.00
- LocationLinical Co Ltd10F, Shin-Osaka Brick Bldg1-6-1, MiyaharaYodogawa-kuOSAKA-SHI 532-0003JapanJPN
- Phone+81 661502478
- Fax+81 661502675
- Websitehttps://www.linical.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ribomic Inc | 0.00 | -1.05bn | 4.51bn | 25.00 | -- | 1.32 | -- | -- | -23.81 | -23.81 | 0.00 | 63.04 | 0.00 | -- | -- | 0.00 | -31.15 | -29.95 | -32.30 | -31.15 | -- | -- | -- | -2,725.95 | 25.20 | -- | 0.00 | -- | -- | -55.55 | 0.5173 | -- | -6.86 | -- |
| Modalis Therapeutics Corp | 0.00 | -2.06bn | 5.16bn | 14.00 | -- | 1.75 | -- | -- | -27.71 | -27.71 | 0.00 | 33.64 | 0.00 | -- | -- | 0.00 | -66.07 | -35.65 | -74.94 | -36.83 | -- | -- | -- | -1,981.18 | -- | -- | 0.0888 | -- | -- | -- | 44.90 | -- | -67.80 | -- |
| D.Western Therapeutics Institute Inc | 419.76m | -1.06bn | 5.43bn | 21.00 | -- | 3.63 | -- | 12.92 | -24.98 | -24.98 | 9.48 | 27.56 | 0.1921 | 0.4194 | 2.71 | 19,988,760.00 | -48.31 | -24.39 | -52.24 | -26.58 | 89.75 | 93.00 | -251.53 | -142.25 | 8.69 | -274.87 | 0.2606 | -- | 10.09 | -4.07 | -58.82 | -- | -- | -- |
| Carna Biosciences, Inc. | 544.45m | -2.19bn | 5.97bn | 63.00 | -- | 6.91 | -- | 10.97 | -114.83 | -114.83 | 28.54 | 45.15 | 0.2413 | 1.12 | 7.38 | 8,642,000.00 | -97.06 | -27.56 | -106.60 | -31.62 | 68.39 | 87.57 | -402.24 | -93.04 | 8.23 | -- | 0.3498 | -- | -60.87 | -27.64 | -88.97 | -- | -20.85 | -- |
| Cyfuse Biomedical KK | -100.00bn | -100.00bn | 6.53bn | 21.00 | -- | 2.20 | -- | -- | -- | -- | -- | 298.18 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 5.80 | -- | 0.3038 | -- | -10.91 | -- | -48.03 | -- | -- | -- |
| Noile-Immune Biotech Inc | 7.14m | -782.47m | 6.58bn | 25.00 | -- | 1.60 | -- | 921.44 | -18.07 | -18.07 | 0.165 | 95.16 | 0.0016 | 0.00 | 0.0668 | 285,720.00 | -17.08 | -- | -17.32 | -- | 30.00 | -- | -10,954.38 | -- | 60.62 | -- | 0.00 | -- | -97.61 | -- | 14.65 | -- | -- | -- |
| TMS Co Ltd | 0.00 | -670.20m | 6.60bn | 18.00 | -- | 2.20 | -- | -- | -15.72 | -15.72 | 0.00 | 65.78 | 0.00 | -- | -- | 0.00 | -21.59 | -- | -22.41 | -- | -- | -- | -- | -- | 23.99 | -- | 0.00 | -- | -- | -- | 31.20 | -- | -- | -- |
| PRISM BioLab Co Ltd | 677.33m | -833.70m | 7.09bn | 35.00 | -- | 2.61 | -- | 10.47 | -22.84 | -22.84 | 18.54 | 73.59 | 0.1779 | -- | 12.58 | 19,352,290.00 | -21.90 | -- | -26.79 | -- | 39.83 | -- | -123.09 | -- | -- | -- | 0.00 | -- | 121.62 | -- | 20.56 | -- | -- | -- |
| OncoTherapy Science, Inc. | 956.86m | -824.72m | 7.53bn | 47.00 | -- | 4.11 | -- | 7.87 | -2.90 | -2.90 | 3.38 | 4.86 | 0.5494 | 6.24 | 21.50 | 20,358,640.00 | -47.35 | -63.66 | -58.01 | -77.43 | 8.44 | -0.3852 | -86.19 | -184.75 | 8.21 | -567.86 | 0.0139 | -- | 22.93 | 18.86 | 36.71 | -- | -70.80 | -- |
| Linical Co Ltd | 9.87bn | -1.19bn | 7.77bn | 598.00 | -- | 1.17 | -- | 0.787 | -52.52 | -52.52 | 437.00 | 267.76 | 0.6226 | -- | 3.69 | 16,505,640.00 | -7.48 | 2.59 | -13.50 | 4.19 | 21.61 | 29.24 | -12.02 | 3.74 | -- | -- | 0.2584 | 77.26 | -15.20 | -0.9283 | -259.37 | -- | -42.01 | 4.24 |
| Medinet Co Ltd | 810.29m | -1.36bn | 7.97bn | 107.00 | -- | 2.10 | -- | 9.84 | -5.15 | -5.15 | 3.06 | 14.27 | 0.1628 | 14.02 | 3.35 | 7,572,813.00 | -27.37 | -22.42 | -28.82 | -23.64 | 13.54 | 17.68 | -168.10 | -173.59 | 15.28 | -- | 0.00 | -- | 5.44 | 0.6867 | -6.67 | -- | 10.06 | -- |
| Chiome Bioscience Inc | 727.99m | -905.53m | 8.06bn | 47.00 | -- | 6.31 | -- | 11.07 | -13.44 | -13.44 | 10.89 | 18.37 | 0.4489 | 6.23 | 13.45 | 15,489,230.00 | -55.84 | -50.30 | -70.30 | -59.73 | 57.33 | 56.21 | -124.39 | -190.32 | 5.37 | -728.13 | 0.0597 | -- | 14.41 | 11.77 | 16.33 | -- | -- | -- |
| Tsubota Laboratory Inc | 973.21m | -172.89m | 8.28bn | 17.00 | -- | 6.41 | -- | 8.51 | -6.79 | -6.79 | 37.61 | 50.08 | 0.4733 | 0.6726 | 4.00 | 57,247,590.00 | -8.41 | 0.1041 | -12.17 | 0.1517 | 80.27 | 71.43 | -17.76 | 0.2216 | 2.89 | -- | 0.0586 | 0.00 | 101.49 | 25.17 | 132.08 | 132.70 | 26.42 | -- |
| Chordia Therapeutics Inc | 0.00 | -1.46bn | 8.82bn | 20.00 | -- | 3.70 | -- | -- | -21.23 | -21.23 | 0.00 | 32.67 | 0.00 | -- | -- | 0.00 | -46.77 | -- | -49.97 | -- | -- | -- | -- | -- | -- | -222.95 | 0.00 | -- | -- | -- | 2.26 | -- | -- | -- |
| BrightPath Biotherapeutics Co Ltd | 1.11m | -1.08bn | 8.96bn | 24.00 | -- | 4.96 | -- | 8,072.24 | -11.59 | -11.59 | 0.0117 | 13.70 | 0.0007 | -- | -- | 46,250.00 | -63.35 | -59.65 | -74.36 | -63.78 | 97.66 | 73.74 | -96,860.36 | -28,727.67 | -- | -1,103.91 | 0.00 | -- | 1,473.61 | -36.87 | 1.45 | -- | -58.41 | -- |
| Nano Holdings Inc | 141.92m | -757.17m | 10.61bn | 20.00 | -- | 3.80 | -- | 74.75 | -10.69 | -10.69 | 2.01 | 36.62 | 0.035 | 98.17 | 16.76 | 7,095,800.00 | -18.65 | -23.68 | -21.92 | -25.37 | 72.64 | 82.69 | -533.54 | -746.83 | 4.10 | -- | 0.00 | -- | -19.92 | -27.80 | -7.10 | -- | -- | -- |
Data as of Feb 06 2026. Currency figures normalised to Linical Co Ltd's reporting currency: Japanese Yen JPY
1.45%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Sawakami Asset Management, Inc.as of 31 Oct 2025 | 348.70k | 1.41% |
| Amova Asset Management Co., Ltd.as of 07 Nov 2024 | 6.20k | 0.03% |
| Dimensional Fund Advisors LPas of 31 Oct 2025 | 2.60k | 0.01% |
| State Street Global Advisors (Japan) Co. Ltd.as of 05 Mar 2024 | 600.00 | 0.00% |
| Nomura Asset Management Co., Ltd.as of 29 Sep 2025 | 400.00 | 0.00% |
| Resona Asset Management Co., Ltd.as of 10 Dec 2024 | 300.00 | 0.00% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 14 Mar 2024 | 100.00 | 0.00% |
| Norinchukin Zenkyoren Asset Management Co., Ltd.as of 27 May 2024 | 100.00 | 0.00% |
| Sumitomo Mitsui DS Asset Management Co., Ltd.as of 10 Sep 2025 | 0.00 | 0.00% |
| Shinkin Asset Management Co., Ltd.as of 18 Jul 2025 | 0.00 | 0.00% |
More ▼
Data from 22 Sep 2025 - 23 Jan 2026Source: FactSet Research Systems Inc.
